We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LIDER:BISTLDR Turizm A.S. Analysis

Data as of 2026-06-01 - not real-time

TRY 116.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical snapshot: LDR Turizm is trading at 116 TRY, just under its 20‑day SMA (117) and well below the 50‑day SMA (122), while the 200‑day SMA sits at 80, keeping the price comfortably above long‑term support. The RSI sits at 46, indicating neutral momentum, but the MACD is bearish with the line below the signal and a negative histogram, and volume is on a decreasing trend. Fundamental backdrop: Revenue has contracted by nearly 20% year‑over‑year, margins are thin (gross 8.6%, operating 6.5%), and both operating and free cash flow are negative despite a strong cash balance. The PE ratio of ~19 is well below the industry average of ~30, suggesting relative cheapness, yet the dividend yield is only 0.12% with an extremely low payout ratio, raising sustainability concerns.
The stock’s volatility is high at 61% over the past 30 days and beta is negative (-0.34), implying high idiosyncratic risk and an inverse move to the broader market. Combined with medium‑level sector and regulatory risks in Turkey and a high currency risk due to the TRY, the overall risk profile leans toward the higher end of the scale. Valuation appears modestly undervalued relative to peers, but the lack of growth and cash‑flow weakness temper enthusiasm.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price trading just below 20‑day SMA
  • Bearish MACD histogram
  • Decreasing volume trend

Medium Term

1–3 years
Neutral
Model confidence: 4/10

Key Factors

  • PE ratio ~19 versus industry ~30 suggests valuation headroom
  • Revenue down 20% YoY and negative operating cash flow
  • High price‑to‑book ratio (10x) indicates limited margin of safety

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained negative free cash flow
  • Minimal dividend yield and questionable payout sustainability
  • Elevated 30‑day volatility (61%) and macro‑economic exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-19.80%
Profit Margin348.67%
P/E Ratio19.0
ROE57.72%
ROA0.01%
Debt/Equity16.80
P/B Ratio10.1
Op. Cash FlowTRY-68796008
Free Cash FlowTRY-1105537664
Industry P/E29.9

Technical Analysis

TrendNeutral
RSI46.3
SupportTRY 101.10
ResistanceTRY 129.50
MA 20TRY 117.00
MA 50TRY 122.35
MA 200TRY 80.85
MACDBearish
VolumeDecreasing
Fear & Greed Index93.29

Valuation

GradeUndervalued
TypeValue
Dividend Yield0.12%

Risk Assessment

Beta-0.34
Volatility61.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.